ArticleResearch square2026
Performance of a two-item sleep quality measure (PSQI-2): a comprehensive evaluation in a multiethnic cohort (MESA Study).
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Objective: To evaluated the abbreviated two-item Pittsburgh Sleep Quality Index (PSQI-2) against the full PSQI in a multi-ethnic cohort. Methods: We analyzed data from 2,237 participants from the MESA Sleep Ancillary Study. The full PSQI was adapted by integrating actigraphy data for sleep duration, latency, and efficiency components, while maintaining the original seven-component structure scored 0-3. The PSQI-2 was derived from two components: sleep duration (questionnaire-based) and subjective sleep quality. Validation analyses included correlation analysis; ROC curves for three PSQI cutpoints (> 5, > 7, >10) with sensitivity/specificity calculations, Bland-Altman analysis for agreement, bootstrap internal validation, and logistic regression for demographic, clinical, and sleep-related covariates. Results: Poor sleep quality was prevalent (65.6% by PSQI > 5; 65.7% by PSQI-2 > 1). The PSQI-2 showed strong correlation with the full PSQI (r = 0.520, p < 0.001), consistent across gender and age subgroups. Both measures identified similar risk patterns: Black and Hispanic participants had higher odds of poor sleep, and obesity, sleep disorders, daytime sleepiness, and evening chronotype consistently increased poor sleep odds. The PSQI-2 demonstrated good discriminant validity across PSQI cutpoints (AUC: 0.785 for > 5, 0.748 for > 7, 0.750 for > 10), with sensitivity ranging from 71.8-86.8% and specificity from 46.3-79.1%. Conclusion: The PSQI-2 shows strong validity and consistent performance with the full PSQI, effectively identifying poor sleep quality and associated factors. Its brevity makes it suitable for large-scale studies and clinical screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.